Abstract
Obsessive-compulsive disorder (OCD) is a chronic and disabling anxiety disorder which affects approximately 1.5 % of the population. The average age of onset is 15 years, but OCD may start at any age although an onset after the age of 35 is viewed as rare. OCD is characterized by obsessions, e.g., images, repetitive thoughts, unwanted impulses to harm, and repetitive behaviors or mental acts (compulsions). Similarly, restricted, repetitive patterns of behavior, interests, or activities characterize autism and are included in the diagnostic criteria for autism spectrum disorder (ASD) in DSM-5. Autistic personality traits are common in patients with OCD, and OCD is likewise common in individuals with ASD. The two conditions share a range of additional communalities: personality disorders within the obsessive-compulsive, avoidant, and schizotypal/schizoid domains; motor clumsiness and soft neurological signs; neuropsychological deficits; serotonergic dysfunction; immunological underpinnings; and a genetic overlap at the molecular level. Cognitive behavioral therapy could be used in OCD regardless of the presence of ASD; however, the outcome is often less favorable in individuals with ASD+OCD compared to those with only OCD or OCD coexisting with a tic disorder.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abudy A, Juven-Wetzler A, Zohar J. Pharmacological management of treatment-resistant obsessive-compulsive disorder. CNS Drugs. 2011;25:585–96.
Altemus M, Jacobson KR, Debellis M, et al. Normal CSF oxytocin and NPY levels in OCD. Biol Psychiatr. 1999;45:931–3.
Anholt GE, Cath DC, van Oppen P, et al. Autism and ADHD symptoms in patients with OCD: are they associated with specific OC symptom dimensions or OC symptom severity. J Autism Dev Disord. 2010;40:580–9.
Baer L, Jenike MA, Black DW, Treece C, Rosenfeld R, Greist J. Effect of axis II diagnoses on treatment outcome with clomipramine in 55 patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1992;49:862–6.
Bannon S, Gonsalves CJ, Croft RJ, Boyce PM. Executive functions in obsessive-compulsive disorder: state or trait deficits? Aust N Z J Psychiatry. 2006;40:1031–8.
Baxter Jr LR, Phleps ME, Mazziotta JC. Local glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry. 1987;44:211–8.
Bedard M-J, Joyal CC, Godbout L, Chantal S. Executive functions and the obsessive-compulsive disorder: on the importance of subclinical symptoms and other concomitant factors. Arch Clin Neuropsychol. 2009;24:585–98.
Bejerot S. An autistic dimension: a proposed subtype of obsessive-compulsive disorder. Autism. 2007;11:101–10.
Bejerot S. Autism spectrum disorders, autistic traits and personality disorders in obsessive compulsive disorder. In: Gross-Isseroff R and Weizman A, editors. Obsessive compulsive disorder and comorbidity, Nova Science; New York. 2006. p. 59–102.
Bejerot S, Nylander L. Low prevalence of smoking in patients with autism spectrum disorders. Psychiatry Res. 2003;15(119):177–82.
Bejerot S, Nylander L, Lindström E. Autistic traits in obsessive-compulsive disorder. Nord J Psychiatry. 2001;55:169–76.
Bienvenu OJ, Samuels JF, Wuyek LA. Is obsessive-compulsive disorder an anxiety disorder, and what, if any, are spectrum conditions? A family study perspective. Psychol Med. 2012;42:1–13.
Canitano R, Scandurra V. Psychopharmacology in autism: an update. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:18–28.
Cath DC, Spinhoven P, Hoogduin CA, et al. Repetitive behaviors in Tourette’s syndrome and OCD with and without tics: what are the differences? Psychiatry Res. 2001;25(101):171–85.
Choudhury PR, Lahiri S, Rajamma U. Glutamate mediated signaling in the pathophysiology of autism spectrum disorders. Pharmacol Biochem Behav. 2012;100:841–9.
Chugani DC, Muzik O, Behen M, et al. Developmental changes in brain serotonin synthesis capacity in autistic and non autistic children. Ann Neurol. 1999;45:287–95.
Cottraux J, Gerard D, Cinotti L, et al. A controlled positron emission tomography study of obsessive and neutral auditory stimulation in obsessive-compulsive disorder with checking rituals. Psychiatry Res. 1996;60:101–12.
Courchesne E, Hesselink JR, Jernigan TL, Yeung Courchesne R. Abnormal neuroanatomy in a nonretarded person with autism. Unusual findings with magnetic resonance imaging. Arch Neurol. 1987;44:335–41.
Gillberg C, Billstedt E. Autism and asperger syndrome: coexistence with other clinical disorders. Acta Psychiatr Scand. 2000;102:321–30.
Gillberg C, Coleman M. Clinical diagnosis. In: Gillberg C, Coleman M, editors. The biology of autistic syndromes. 3rd ed. Cambridge: Cambridge University Press; 2000. p. 4–38.
Gillott A, Furniss F, Walter A. Anxiety in high-functioning children with autism. Autism. 2001;5:277–86.
Goddard AW, Shekhar A, Whiteman AF, McDougle CJ. Serotonergic mechanisms in the treatment of obsessive-compulsive disorder. Drug Discov Today. 2008;13:325–32.
Gross-Isseroff R, Kindler S, Kotler M, et al. Pharmacological challenges. In: Hollander E, Zohar J, Marazziti D, Olivier B, editors. Current insights in obsessive compulsive disorder. Chichester: Wiley; 1994. p. 137–47.
Gross-Isseroff R, Cohen R, Sasson Y, et al. Serotonergic dissection of obsessive compulsive symptoms: a challenge study with mCPP and sumatriptan. Neuropsychobiol. 2004;50:200–5.
Guo H, Hu Z, Zhao J, Xia K. Genetics of autism spectrum disorders. Zhong Nan Da XueBao Yi Xue Ban. 2011;8:703–11.
Hallmayer J, Cleveland S, Torres A, et al. Genetic heritability and shared environmental factors among twin pairs with autism. Arch Gen Psychiatry. 2011;68:1095–102.
Herault J, Petit E, Martineau J, et al. Serotonin and autism: biochemical and molecular biology features. Psychiatry Res. 1996;65:33–43.
Hewlett WA, Vinogradov S, Martin K, et al. Fenfluramine stimulation of prolactin in obsessive compulsive disorder. Psychiatry Res. 1992;42:81–92.
Hofvander B, Delorme R, Chaste P, et al. Psychiatric and psychosocial problems in adults with normal-intelligence autism spectrum disorders. BMC Psychiatry. 2009;9:35.
Hollander E, DeCaria CM, Nitescu A, et al. Serotonergic function in obsessive compulsive disorder. Arch Gen Psychiatry. 1992;49:21–8.
Hollander E, Novotny S, Allen A, et al. The relationship between repetitive behaviors and growth hormone response to sumatriptan challenge in adult autistic disorder. Neuropsychopharmacology. 2000;22:163–7.
Hollander E, Anagnostou E, Chaplin W, et al. Striatal volume on magnetic resonance imaging and repetitive behaviors in autism. Biol Psychiatry. 2005;58:226–32.
HottPian KL, Westenberg HG, den Boerr JA, et al. Effects of meta-chlorophenylpiperazine on cerebral blood flow in obsessive-compulsive disorder. Biol Psychiatry. 1998;44:367–70.
Insel TR, Mueller EA, Alterman J. Obsessive compulsive disorder and serotonin: is there a connection? Biol Psychiatry. 1985;20:1174–88.
Insel TR, O’Brien DJ, Leckman JF. Oxytocin, vasopressin, and autism: is there a connection? Biol Psychiatry. 1999;45:145–57.
Ivarsson T, Melin K. Autism spectrum traits in children and adolescents with obsessive compulsive disorder (OCD). J Anxiety Disord. 2008;22:969–78.
Kaland N, Callesen K, Moller-Nielsen A, et al. Performance of children and adolescents with asperger syndrome or high functioning autism on advanced theory of mind tasks. J Autism Dev Disord. 2008;38:1112–23.
King BH, Bostic JQ. An update on pharmacologic treatments for autism spectrum disorders. Child Adolesc Psychiatric Clin N Am. 2006;15:161–75.
Kobayashi R, Murata T. Behavioral characteristics of 187 young adults with autism. Psychiatry Clin Neurosci. 1998;52:383–90.
KollinsSH MCFJ, Fuemmeler BF. Association between smoking and attention-deficit/hyperactivity disorder symptoms in a population-based sample of young adults. Arch Gen Psychiatry. 2005;62:1142–7.
Langen M, Schnack HG, Nederveen H, et al. Changes in the developmental trajectories of striatum in autism. Biol Psychiatry. 2009;66:327–33.
Langen M, Durston S, Kas MJH, et al. The neurobiology of repetitive behavior: … and men. Neurosci Biobehav Rev. 2011;35:356–65.
Leboyer M, Philippe A, Bouvard M, et al. Whole blood serotonin and plasma beta-endorphin in autistic probands and their first degree relatives. Biol Psychiatry. 1999;45:158–65.
Lochner C, Serebro P, van der Merwe L. Comorbid obsessive-compulsive personality disorder in obsessive-compulsive disorder (ocd): a marker of severity. Prog Neuropsychopharm Biol Psychiatry. 2011;35:1087–92.
Lugnegård T, Hallerbäck MU, Gillberg C. Psychiatric comorbidity in young adults with a clinical diagnosis of asperger syndrome. Res Dev Disabil. 2011;32:1910–7.
Mathews CA, Nievergelt CM, Azzam A, et al. Heritability and clinical features of multigenerational families with obsessive-compulsive disorder and hoarding. Am J Med Genet B Neuropsychiatr Genet. 2007;144B:174–82.
McBride PA, Anderson GM, Hertzig ME, et al. Serotonergic responsivity in male young adults with autistic disorder. Results of a pilot study. Arch Gen Psychiatry. 1989;46:213–21.
McBride PA, Anderson GM, Hertzig ME, et al. Effects of diagnosis, race, and puberty on platelet serotonin levels in autism and mental retardation. J Am Acad Child Adolesc Psychiat. 1998;37:767–76.
McDougle CJ, Kresch LE, Goodman WK, et al. A case–control study of repetitive thoughts and behavior in adults with autistic disorder and obsessive-compulsive disorder. Am J Psychiatry. 1995;152:772–7.
McDougle CJ, Naylor ST, Cohen DJ, et al. Effects of tryptophan depletion in drug free adults with autistic disorder. Arch Gen Psychiatry. 1996;53:993–1000.
McPheeters ML, Warren Z, Sathe N, et al. A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics. 2011;127:e1312–21.
Muller RA, Behen ME, Rothermel RD, et al. Brain mapping of language and auditory perception in high-functioning autistic adults: a PET study. J Autism Dev Disord. 1999;29:19–31.
Muthugovindan D, Singer H. Motor stereotypy disorders. Curr Opin Neurol. 2009;22(2):131–6.
Pertusa A, Bejerot S, Eriksson J, et al. Do patients with hoarding disorder have autistic traits? Depress Anxiety. 2012;29:210–8.
Pian KL, Westenberg HG, van Megen HJ, den Boer JA. Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder. Psychopharm Berl. 1998;140:365–70.
Pinto PS, Iego S, Nunes S, et al. Influence of specific obsessive-compulsive symptom dimensions on strategic planning in patients with obsessive-compulsive disorder. Rev Bras Psiquiatr. 2011;33:40–6.
Pisula E. The autistic mind in the light of neuropsychological studies. Acta Neurobiol Exp. 2010;70:119–30.
Pittenger C, Bloch MH, Williams K. Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment. Pharmacol Ther. 2011;132:314–32.
Rauch SL, Jenike MA, Alpert NM, Baer L, Breiter HC, Savage CR, Fischman AJ. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positronemission tomography. Arch Gen Psychiatry. 1994;51(1):62–70.
Rauch SL, Savage CR, Alpert NM, Dougherty D, Kendrick A, Curran T, Brown HD, Manzo P. Fischman AJ, Jenike MA. Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning. J Neuropsychiatry Clin Neurosci. 1997;9:568–73.
Rojas DC, Peterson E, Winterrowd E, et al. Regional gray matter volumetric changes in autism associated with social and repetitive behavior symptoms. BMC Psychiatry. 2006;6:56–69.
Rossi A, Daneluzzo E. Schizotypal dimensions in normals and schizophrenic patients: a comparison with other clinical samples. Schizophr Res. 2002;54:67–75.
Rubin RT, Villanueva Meyer J, Ananth J. Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high resolution single-photon emission computed tomography. Arch Gen Psychiatry. 1992;49:695–702.
Russell AJ, Jassi A, Fullana MA, Mack H, Johnston K, Heyman I, Murphy DG, Mataix-Cols D. Cognitive behavior therapy for comorbid obsessive-compulsive disorder in high-functioning autism spectrum disorders: a randomized controlled trial. Depress Anxiety. 2013. doi: 10.1002/da.22053.
Russell AJ, Mataix-Cols D, Anson M, Murphy DG. Obsessions and compulsions in asperger syndrome and high-functioning autism. Br J Psychiatry. 2005;186:525–8.
Ruta L, Mugno D, D’Arrigo VG, et al. Obsessive-compulsive traits in children and adolescents with asperger syndrome. Eur Child Adolesc Psychiatry. 2010;19:17–24.
Rydén E, Bejerot S. Autism spectrum disorders in an adult psychiatric population. A naturalistic cross-sectional controlled study. Clin Neuropsychiatry. 2008;5:13–21.
Safran M, Dalah I, Alexander J, et al. GeneCards version 3: the human gene integrator database. 2010. doi:10.1093/database/baq020[PDF]
Simons JM. Observations on compulsive behavior in autism. J Autism Child Schizophr. 1974;4:1–10.
Singh VK, Singh EA, Warren RP. Hyperserotonemia and serotonin receptor antibodies in children with autism but not mental retardation. Biol Psychiatry. 1997;41:753–5.
Stanley MA, Turner SM, Borden JW. Schizotypal features in obsessive-compulsive disorder. Compr Psychiatry. 1990;31:511–8.
Stein DJ, Van-Heerden B, Van-Kradenburg J, et al. Single photon emission computed tomography of the brain with Tc-99mHMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor. Prog Neuropsychopharm Biol Psychiatry. 1999;23:1079–99.
Thakkar K, Polli F, Joseph R, et al. Response monitoring, repetitive behaviour and anterior cingulate abnormalities in autism spectrum disorders (asd). Brain. 2008;131:2464–78.
Thoren P, Asberg M, Bertilsson L, et al. Clomipramine treatment of obsessive compulsive disorder II: biochemical aspects. Arch Gen Psychiatry. 1980;37:1289–94.
Torres AR, Fontenelle LF, Ferrão YA, do Rosário MC, Torresan RC, Miguel EC,Shavitt RG. Clinical features of obsessive-compulsive disorder with hoardingsymptoms: a multicenter study. J Psychiatr Res. 2012;46(6):724–32.
Tsatsanis KD, Noens IL, Illmann CL. Managing complexity: impact of organization and processing style on nonverbal memory in autism spectrum disorders. J Autism Dev Disord. 2011;41:135–47.
Warren RP, Singh VK. Elevated serotonin levels in autism: association with major histocompatibility complex. Neuropsychobiology. 1996;34:72–5.
Weizman R, Gil-Ad I, Tyano S, et al. Low plasma immunoreactive beta-endorphin levels in autism. J Am Acad Child Adolesc Psychiatry. 1988;27:430–3.
Weizman R, Gil-Ad I, Hermesh H, et al. Immunoreactive beta-endorphin, cortisol, and growth hormone plasma levels in obsessive-compulsive disorder. Clin Neuropharmacol. 1990;13:297–302.
Westen D, Shedler J. Revising and assessing axis II. Part II: toward an empirically based and clinically useful classification of personality disorders. Am J Psychiatry. 1999;156:273–85.
Wilcox JA, Tsuang MT, Schnurr T, Baida-Fragoso N. Case–control family study of lesser variant traits in autism. Neuropsychobiology. 2003;47:171–7.
Wing L. The relationship between Asperger’s syndrome and Kanner’s autism. In: Frith U, editor. Autism and asperger syndrome. Cambridge: Cambridge University Press; 1991. p. 93–121.
Wink LK, Plawecki MH, Erickson CA, et al. Emerging drugs for the treatment of symptoms associated with autism spectrum disorders. Expert Opin Emerg Drugs. 2010;15:481–94.
Zohar J, Insel TR, Berman KF. Anxiety and cerebral blood flow during behavioral challenge. Dissociation of central from peripheral and subjective measures. Arch Gen Psychiatry. 1989;46:505–10.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this entry
Cite this entry
Bejerot, S., Weizman, A., Gross-Isseroff, R. (2014). Communality between Obsessive Compulsive Disorder and Autism Spectrum Disorders. In: Patel, V., Preedy, V., Martin, C. (eds) Comprehensive Guide to Autism. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4788-7_32
Download citation
DOI: https://doi.org/10.1007/978-1-4614-4788-7_32
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-4787-0
Online ISBN: 978-1-4614-4788-7
eBook Packages: Behavioral Science